Inogen INGN
NASDAQ INGN
$5.27 +0.04 (+0.77%)
As of: Sep 9, 2026 · 3:59 PM EDT

Inogen (INGN) Cash & Current Investments (2012 - 2026)

Inogen's (INGN) quarterly Cash & Current Investments came in at $105.5 million in Q2 2026, down 13.8% year-over-year from $122.4 million in Q2 2025, and down 4.2% quarter-over-quarter from $110.2 million in Q1 2026.

Analysis

Inogen (INGN) Cash & Current Investments (2012 - 2026) Analysis & Trends

Inogen (INGN) has reported Cash & Current Investments for 15 consecutive years, with $105.5 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash & Current Investments fell 13.8% year-over-year to $105.5 million in Q2 2026; TTM through Jun 2026 was $105.5 million, a 13.8% decrease from a year earlier, with the FY2025 full-year figure at $119.6 million, down 1.2% from the prior year.
  • Cash & Current Investments was $105.5 million for Q2 2026 at Inogen, down from $110.2 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $223.6 million in Q2 2022 and troughed at $105.5 million in Q2 2026.
  • A 5-year average of $149.3 million and a median of $122.9 million in 2025 frame the typical range for Cash & Current Investments.
  • Across the five-year window, Cash & Current Investments tumbled 37.62% in 2023 and rose 4.03% in 2025, its largest moves.
  • Over 5 years, Cash & Current Investments stood at $206.0 million in 2022, then plunged by 37.62% to $128.5 million in 2023, then fell by 5.79% to $121.0 million in 2024, then dropped by 1.2% to $119.6 million in 2025, then decreased by 11.74% to $105.5 million in 2026.
  • The last three Cash & Current Investments figures came in at $105.5 million (Q2 2026), $110.2 million (Q1 2026), and $119.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 5.60 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 5.22 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 8.82 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 3.48 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 539.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 4.25 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 1.46 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 1.95 Bn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 482.30 Mn
10 Inogen 142.58 Mn 37.04 Mn 43.27 Mn 105.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 105.54 Mn
Mar 31, 2026 110.17 Mn
Dec 31, 2025 119.58 Mn
Sep 30, 2025 123.22 Mn
Jun 30, 2025 122.43 Mn
Mar 31, 2025 122.54 Mn
Dec 31, 2024 121.04 Mn
Sep 30, 2024 120.66 Mn
Jun 30, 2024 117.69 Mn
Mar 31, 2024 119.81 Mn
Dec 31, 2023 128.47 Mn
Sep 30, 2023 138.04 Mn
Jun 30, 2023 187.61 Mn
Mar 31, 2023 179.06 Mn
Dec 31, 2022 205.95 Mn
Sep 30, 2022 218.11 Mn
Jun 30, 2022 223.62 Mn
Mar 31, 2022 223.39 Mn
Dec 31, 2021 245.51 Mn
Sep 30, 2021 245.13 Mn